Thrombocytopenia as a prognostic factor in Hispanic patients with systemic lupus erythematosus: Comment on the article by Fernández et al

2007 ◽  
Vol 56 (8) ◽  
pp. 2811-2812 ◽  
Author(s):  
Cristina Drenkard ◽  
Antonio R. Villa
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Prognostic Factor ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Hispanic Patients

Is Renal Vasculitis in Patients with Systemic Lupus erythematosus a Bad Prognostic Factor?

2015 ◽  
pp. 72-78 ◽  
Author(s):  
Paolo Altieri ◽  
Antonello Pani ◽  
Piergiorgio Bolasco ◽  
Patrizia Melis ◽  
Antonio Barracca ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Prognostic Factor ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Renal Vasculitis

scholarly journals Immunoglobulin G Levels as a Prognostic Factor for Autoimmune Hepatitis Combined With Systemic Lupus Erythematosus

2016 ◽  
Vol 68 (7) ◽  
pp. 995-1002 ◽  
Author(s):  
Doo-Ho Lim ◽  
Yong-Gil Kim ◽  
Danbi Lee ◽  
Soo Min Ahn ◽  
Seokchan Hong ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Prognostic Factor ◽  
Autoimmune Hepatitis ◽  
Immunoglobulin G ◽  
Lupus Erythematosus ◽  
Systemic Lupus

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients

Lupus ◽  
2009 ◽  
Vol 19 (2) ◽  
pp. 213-219 ◽  
Author(s):  
M. Garcia-Carrasco ◽  
C. Mendoza-Pinto ◽  
M. Sandoval-Cruz ◽  
E. Soto-Vega ◽  
A. Beltran-Castillo ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Longitudinal Analysis ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Hispanic Patients ◽  
Anti Cd20

Abstract TP205: Cerebrovascular Diseases in Hispanic Patients With Systemic Lupus Erythematosus

Stroke ◽  
2018 ◽  
Vol 49 (Suppl_1) ◽  
Author(s):  
Carlos Cantú-Brito ◽  
Paola Guraieb-Chaín ◽  
Sergio I Valdés-Ferrer ◽  
Adriãn Soto-Mota ◽  
Lorena Guerrero-Torres ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Cerebrovascular Diseases ◽  
Systemic Lupus ◽  
Hispanic Patients

Thyroid nodules in Hispanic patients with systemic lupus erythematosus

Lupus ◽  
2013 ◽  
Vol 22 (14) ◽  
pp. 1509-1513 ◽  
Author(s):  
DL Quintanilla-Flores ◽  
MI Hernández-Coria ◽  
G Elizondo-Riojas ◽  
DA Galarza-Delgado ◽  
JG González-González ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Thyroid Nodules ◽  
Systemic Lupus ◽  
Hispanic Patients

Time of initial appearance of renal symptoms in the course of systemic lupus erythematosus as a prognostic factor for lupus nephritis

2009 ◽  
Vol 19 (3) ◽  
pp. 293-301 ◽  
Author(s):  
Yuko Takahashi ◽  
Tetsuya Mizoue ◽  
Akitake Suzuki ◽  
Hiroyuki Yamashita ◽  
Junwa Kunimatsu ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Prognostic Factor ◽  
Lupus Nephritis ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Initial Appearance

Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor

2007 ◽  
Vol 56 (2) ◽  
pp. 614-621 ◽  
Author(s):  
Mónica Fernández ◽  
Graciela S. Alarcón ◽  
Mandar Apte ◽  
Rosa M. Andrade ◽  
Luis M. Vilá ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Prognostic Factor ◽  
Lupus Erythematosus ◽  
Systemic Lupus

Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome

Lupus ◽  
2020 ◽  
Vol 29 (5) ◽  
pp. 437-445
Author(s):  
P Guraieb-Chahín ◽  
C Cantú-Brito ◽  
A Soto-Mota ◽  
L Guerrero-Torres ◽  
F Flores-Silva ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Stroke Recurrence ◽  
Systemic Lupus ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Hispanic Patients ◽  
Ischemic Attack ◽  
Demographical Data

Objective To determine stroke prevalence, mechanisms, and long-term outcome in a cohort of Hispanic patients with systemic lupus erythematosus (SLE). Methods We analyzed demographical data, the timing between SLE diagnosis and stroke onset, stroke type, recurrence, and outcomes from an institutional database of 4451 patients with SLE followed from 1993 to 2018. Results We observed 139 strokes (3.1%), for an incidence rate of 1.25 per 1000 person-years: 81 (58.3%) acute ischemic stroke (AIS), 19 (13.7%) subarachnoid hemorrhage (SAH), 17 (12.2%) cerebral venous thrombosis, 13 (9.4%) intracerebral hemorrhage (ICH), and 9 (6.5%) transient ischemic attack. Median time from SLE diagnosis to acute stroke was 60 months (interquartile range 12–132 months). AIS had a bimodal presentation with 26% occurring within the first year and 30% >10 years after SLE diagnosis. In contrast, 75% of ICH cases occurred >3 years (and 34% >10 years) after SLE diagnosis. The most important cause of AIS was secondary antiphospholipid syndrome (48%). Hypertension was associated with 69% of ICH cases, while aneurysmal rupture was observed in 78% of SAH cases. Excellent recovery at hospital discharge was observed in 65%. Stroke recurrence was observed in 7%. The long-term all-cause fatality rate was 8%. Conclusions The prevalence of stroke in this cohort was 3.1%. Ischemic strokes had a bimodal presentation, occurring either early after SLE diagnosis or after a several-year delay. Half of the hemorrhagic strokes occurred >10 years after the diagnosis of SLE. Clinical outcome was usually good with a relatively low recurrence rate.

Sign in / Sign up

Export Citation Format

Share Document